Intermittent immunotherapy in patients with metastatic kidney cancer
The combination of ipilimumab/nivolumab is approved for patients as a [...]
The combination of ipilimumab/nivolumab is approved for patients as a [...]
The standard of care for patients with intermediate/high risk kidney [...]
At the American Society of Clinical Oncology Annual Meeting (ASCO) last [...]
The National Institute for Health and Care Excellence (NICE) has approved the [...]
The CheckMate-214 clinical trial was the first study to show [...]
An injectable form of nivolumab has been successful in clinical [...]
A recent study published in the journal JAMA Oncology has [...]
Updated results and further follow up from the CaboNivo study [...]
The results of a study with a new anti-cancer medication [...]
The COSMIC-313 study previously showed improved survival when combining cabozantinib [...]